v1
Phase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancer.
Identifier:nobleid.org/w1/20260515/FCDCD6BC
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/FCDCD6BC)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims